Impact of frontline treatment approach on outcomes of myeloid blast phase CML

BACKGROUND: The natural course of untreated chronic myeloid leukemia (CML) is progression to an aggressive blast phase. Even in the current era of BCR-ABL1 tyrosine kinase inhibitors (TKIs), the outcomes of blast phase CML remain poor with no consensus frontline treatment approach. METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Kapil, Jabbour, Elias, Issa, Ghayas, Sasaki, Koji, Ravandi, Farhad, Maiti, Abhishek, Daver, Naval, Kadia, Tapan, DiNardo, Courtney D., Konopleva, Marina, Cortes, Jorge E., Yilmaz, Musa, Chien, Kelly, Pierce, Sherry, Kantarjian, Hagop, Short, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204504/
https://www.ncbi.nlm.nih.gov/pubmed/34130720
http://dx.doi.org/10.1186/s13045-021-01106-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204504/
https://www.ncbi.nlm.nih.gov/pubmed/34130720
http://dx.doi.org/10.1186/s13045-021-01106-1

Ejemplares similares